Finance

Lists
688506:SHA
Sichuan Biokin Pharmaceutical Co Ltd
232,72 CN¥
-0,50%
(-1,16) 1D
19 հոկ, 10:51:14 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688506...
Open
231,88 CN¥
High
236,87 CN¥
Low
226,80 CN¥
Mkt. cap
96,56 մլրդ
Avg. vol.
1,60 մլն
Volume
656,28 հզր
52-wk high
404,00 CN¥
52-wk low
200,10 CN¥
EPS
-3,79 CN¥
No. of employees
3 հզր
Open
231,88 CN¥
High
236,87 CN¥
Low
226,80 CN¥
Mkt. cap
96,56 մլրդ
Avg. vol.
1,60 մլն
Volume
656,28 հզր
52-wk high
404,00 CN¥
52-wk low
200,10 CN¥
EPS
-3,79 CN¥
No. of employees
3 հզր
News stories
From web sources and news partners
Profile
Sichuan Biokin Pharmaceutical Co., Ltd. is a publicly listed Chinese biopharmaceutical company that is headquartered in Chengdu, Sichuan. Wikipedia
About Sichuan Biokin Pharmaceutical Co Ltd
CEO-
Employees3,43 հզր
Founded23 օգս, 1996 թ.
Headquarters-
Sector-
Websiteen.baili-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
1,89 մլրդ
454,22 մլն
94,59 մլն
92,75 մլն
Cost of goods sold
43,74 մլն
115,66 մլն
43,37 մլն
59,34 մլն
Cost of revenue
43,74 մլն
115,66 մլն
43,37 մլն
59,34 մլն
Research and development expenses
733,75 մլն
741,34 մլն
694,76 մլն
787,93 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
144,15 մլն
169,94 մլն
126,35 մլն
113,01 մլն
Operating expense
862,71 մլն
926,05 մլն
813,01 մլն
892,42 մլն
Total operating expenses
906,45 մլն
1,04 մլրդ
856,38 մլն
951,76 մլն
Operating income
988,25 մլն
-587,49 մլն
-761,79 մլն
-859,01 մլն
Other non operating income
-68,11 մլն
68,05 մլն
-142,74 մլն
142,75 մլն
EBT including unusual items
942,32 մլն
-535,84 մլն
-776,15 մլն
-901,42 մլն
EBT excluding unusual items
977,50 մլն
-586,93 մլն
-841,61 մլն
-965,12 մլն
Income tax expense
318,88 մլն
23,26 մլն
-1,59 մլն
-38,76 մլն
Effective tax rate
33,84%
-4,34%
0,21%
4,30%
Other operating expenses
-15,12 մլն
14,55 մլն
-7,43 մլն
-9,01 մլն
Net income
623,44 մլն
-559,10 մլն
-774,56 մլն
-862,66 մլն
Net profit margin
32,90%
-123,09%
-818,89%
-930,11%
Earnings per share
-
-
-
-
Interest and investment income
54,03 մլն
56,43 մլն
89,48 մլն
36,67 մլն
Interest expense
-24,43 մլն
-26,18 մլն
-26,56 մլն
-29,06 մլն
Net interest expenses
29,60 մլն
30,26 մլն
62,92 մլն
7,62 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
1,01 մլրդ
-567,21 մլն
-741,51 մլն
-836,43 մլն
Gain or loss from assets sale
1,06 հզր
-1,06 հզր
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps